NFLX vs TGTX · P/E 25, rev $12.56B vs P/E 18, rev $240.3M
Netflix Inc (NFLX) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
NFLX currently screens at market cap $324.06B and trailing P/E 24.8. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the NFLX and TGTX stock pages for the full models.
Not investment advice.